Veracyte Stock Market Value
| VCYT Stock | USD 42.89 0.05 0.12% |
| Symbol | Veracyte |
Veracyte Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Veracyte. If investors know Veracyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Veracyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.13) | Revenue Per Share 5.644 | Quarterly Revenue Growth 0.286 | Return On Assets 0.0107 | Return On Equity (0.01) |
The market value of Veracyte is measured differently than its book value, which is the value of Veracyte that is recorded on the company's balance sheet. Investors also form their own opinion of Veracyte's value that differs from its market value or its book value, called intrinsic value, which is Veracyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Veracyte's market value can be influenced by many factors that don't directly affect Veracyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Veracyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Veracyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Veracyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Veracyte 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Veracyte's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Veracyte.
| 09/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in Veracyte on September 30, 2024 and sell it all today you would earn a total of 0.00 from holding Veracyte or generate 0.0% return on investment in Veracyte over 60 days. Veracyte is related to or competes with Crinetics Pharmaceuticals, Viridian Therapeutics, Cytokinetics, Structure Therapeutics, Kura Oncology, Protagonist Therapeutics, and Merus BV. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with i... More
Veracyte Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Veracyte's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Veracyte upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.66 | |||
| Information Ratio | 0.1289 | |||
| Maximum Drawdown | 14.52 | |||
| Value At Risk | (3.99) | |||
| Potential Upside | 5.42 |
Veracyte Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Veracyte's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Veracyte's standard deviation. In reality, there are many statistical measures that can use Veracyte historical prices to predict the future Veracyte's volatility.| Risk Adjusted Performance | 0.1407 | |||
| Jensen Alpha | 0.3144 | |||
| Total Risk Alpha | 0.0554 | |||
| Sortino Ratio | 0.1342 | |||
| Treynor Ratio | 0.3452 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Veracyte's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Veracyte Backtested Returns
Veracyte appears to be very steady, given 3 months investment horizon. Veracyte owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.21, which indicates the firm had a 0.21% return per unit of risk over the last 3 months. By inspecting Veracyte's technical indicators, you can evaluate if the expected return of 0.59% is justified by implied risk. Please review Veracyte's Risk Adjusted Performance of 0.1407, semi deviation of 2.25, and Coefficient Of Variation of 574.04 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Veracyte holds a performance score of 16. The entity has a beta of 1.37, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Veracyte will likely underperform. Please check Veracyte's sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to make a quick decision on whether Veracyte's existing price patterns will revert.
Auto-correlation | 0.01 |
Virtually no predictability
Veracyte has virtually no predictability. Overlapping area represents the amount of predictability between Veracyte time series from 30th of September 2024 to 30th of October 2024 and 30th of October 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Veracyte price movement. The serial correlation of 0.01 indicates that just 1.0% of current Veracyte price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.01 | |
| Spearman Rank Test | 0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 7.09 |
Veracyte lagged returns against current returns
Autocorrelation, which is Veracyte stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Veracyte's stock expected returns. We can calculate the autocorrelation of Veracyte returns to help us make a trade decision. For example, suppose you find that Veracyte has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Veracyte regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Veracyte stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Veracyte stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Veracyte stock over time.
Current vs Lagged Prices |
| Timeline |
Veracyte Lagged Returns
When evaluating Veracyte's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Veracyte stock have on its future price. Veracyte autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Veracyte autocorrelation shows the relationship between Veracyte stock current value and its past values and can show if there is a momentum factor associated with investing in Veracyte.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Veracyte Stock Analysis
When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.